advertisement

Topcon

Pasinetti GM 2

Showing records 1 to 2 | Display all abstracts from Pasinetti GM

46162 Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: A 6-month efficacy and tolerability, multicenter, open-label prospective study
Rossi GCM; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
Expert Opinion in Pharmacotherapy 2011; 12: 685-690
46090 Do adherence rates and glaucomatous visual field progression correlate?
Rossi GCM; Pasinetti GM; Scudeller L; Radaelli R; Bianchi PE
European Journal of Ophthalmology 2011; 21: 410-414

Issue 13-2

Change Issue


advertisement

Oculus